Average Insider

Where insiders trade, we follow

$TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Healthcare
Sector
Medical - Healthcare Information Services
Industry
Serge Saxonov
CEO
1306
Employees
$65.60
Current Price
$2.60B
Market Cap
52W Low$11.16
Current$65.6097.6% above low, 2.4% below high
52W High$66.94

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00--All Sells
Sells13$1,235,071.6220,000
1 monthBuys00--All Sells
Sells613$5,597,216.3289,773
2 monthsBuys00--All Sells
Sells615$6,752,271.72109,773
3 monthsBuys00--All Sells
Sells621$7,972,296.46145,496
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Sep 3, 2026
STUELPNAGEL JOHN R
Director
Sale6,174$62.61$386,533.15View Details
Sep 3, 2026
STUELPNAGEL JOHN R
Director
Sale7,012$60.66$425,333.19View Details
Sep 3, 2026
STUELPNAGEL JOHN R
Director
Sale6,814$62.11$423,205.27View Details
Aug 26, 2026
Saxonov Serge
Director
Sale6,494$63.98$415,465.34View Details
Aug 26, 2026
Saxonov Serge
Director
Sale3,500$63.02$220,580.15View Details
Aug 26, 2026
Saxonov Serge
Director
Sale492$64.75$31,855.28View Details
Aug 24, 2026
Saxonov Serge
Director
Sale18,545$63.02$1,168,774.52View Details
Aug 24, 2026
Taich Adam
Chief Financial Officer
Sale17,166$63.02$1,081,852.82View Details
Aug 24, 2026
Hindson Benjamin J.
Director
Sale13,818$63.02$870,860.10View Details
Aug 24, 2026
SULIMAN SHEHNAAZ
Director
Sale561$62.73$35,189.23View Details
Aug 24, 2026
SULIMAN SHEHNAAZ
Director
Sale1,646$63.97$105,288.69View Details
Aug 13, 2026
Teichmann Sarah A.
Director
Sale5,278$57.29$302,376.62View Details
Aug 14, 2026
Teichmann Sarah A.
Director
Sale2,273$57.15$129,901.95View Details
Aug 11, 2026
STUELPNAGEL JOHN R
Director
Sale17,000$57.58$978,880.40View Details
Aug 11, 2026
STUELPNAGEL JOHN R
Director
Sale3,000$58.73$176,175.00View Details
Jun 22, 2026
Saxonov Serge
Director
Sale9,991$34.28$342,506.47View Details
Jun 22, 2026
Saxonov Serge
Director
Sale1,661$36.16$60,069.40View Details
Jun 22, 2026
Saxonov Serge
Director
Sale9,821$35.32$346,837.45View Details
Jun 22, 2026
Saxonov Serge
Director
Sale8,527$33.29$283,855.30View Details
Jun 16, 2026
SULIMAN SHEHNAAZ
Director
Sale364$33.27$12,111.66View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.7.3